The project, launched in June 2024 and set for full operation in mid-2026, has received strong backing from local authorities. This investment, said Sisson, reinforces Lin-gang's position in the global aviation value chain and injects fresh momentum into international collaboration.

Zhang Yan, general manager of GSK (Shanghai) Pharmaceuticals Limited, talked about the recent establishment of GSK's wholly-owned subsidiary in Lin-gang, which will support production of key treatments for hepatitis and depression, while contributing to China's pharmaceutical innovation ecosystem.

Around 100 UK business representatives attended the London conference, which is part of the 2025 Lin-gang Special Area Global Investment Promotion series.